INDV – indivior plc (US:NASDAQ)
Stock Stats
News
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month
Indivior PLC (NASDAQ: INDV) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $16.00 price target on the stock, up previously from $15.00.
Indivior PLC (INDV) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Form 6-K INDIVIOR PLC For: Nov 19
Form 6-K INDIVIOR PLC For: Nov 18
Form SC 13G INDIVIOR PLC Filed by: Flynn James E
Form 6-K INDIVIOR PLC For: Nov 15
Form SC 13G/A INDIVIOR PLC Filed by: SCOPIA CAPITAL MANAGEMENT LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.